BDNF as a potential biomarker for the fibromyalgia-like model in male wistar rats

Authors

  • Vanessa Silva de Souza Post-Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal Rio Grande do Sul, Porto Alegre - RS, Brasil. Laboratory of Pain Pharmacology and Neuromodulation: Pre-Clinical Research – Center of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre - RS, Brasil.
  • Liciane Fernandes Medeiros Post-Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil. Laboratory of Pain Pharmacology and Neuromodulation: Pre-Clinical Research – Center of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil. Post-Graduate Program in Health and Human Development, Universidade La Salle,Canoas, RS, Brasil.
  • Dirson João Stein Laboratory of Pain Pharmacology and Neuromodulation: Pre-Clinical Research – Center of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil. https://orcid.org/0000-0003-0696-0195
  • Camila Lino de Oliveira Post-Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil. Laboratory of Pain Pharmacology and Neuromodulation: Pre-Clinical Research – Center of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil.
  • Helouise Richardt Medeiros Post-Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil. Laboratory of Pain Pharmacology and Neuromodulation: Pre-Clinical Research – Center of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil. https://orcid.org/0000-0001-5756-8076
  • Jairo Dussan-Sarria Faculty of Medicine, Universidade Feevale, Novo Hamburgo, RS, Brasil. https://orcid.org/0000-0002-1271-0638
  • Iraci Lucena da Silva Torres Post-Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil. Laboratory of Pain Pharmacology and Neuromodulation: Pre-Clinical Research – Center of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil. https://orcid.org/0000-0002-3081-115X
  • Andressa Souza Post-Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil.

DOI:

https://doi.org/10.22491/2357-9730.127156

Keywords:

fibromyalgia, rats, BDNF, tnf-alpha

Abstract

Introduction: Fibromyalgia syndrome is characterized by central sensitization, with imbalance between the descending pain inhibition pathways and the ascending pain signaling pathways, including changes in the serotonergic, dopaminergic and catecholaminergic circuits. The aim was to evaluate the nociceptive response, depression-like behavior, and central and peripheral biomarkers levels (BDNF and TNF-ɑ) in male adult Wistar rats submitted to a fibromyalgia-like model induced by reserpine. Methods: Sixteen male adult Wistar rats were allocated by weight in control and fibromyalgia groups. Mechanical and thermal hyperalgesia were evaluated by Von Frey test and Hot Plate test respectively, and depression-like behavior was evaluated by Forced Swim test. Also BDNF and TNF-ɑ were measured in serum and central structures. Results: Rats in the fibromyalgia group presented a lower thermal and mechanical threshold, and an increased immobility time. also reduced serum BDNF levels, without changes in TNF-ɑ levels. There was a positive correlation between mechanical and thermal nociceptive threshold and serum BDNF levels, and a negative correlation between thermal nociceptive threshold and spinal cord BDNF levels. Also, there was a negative correlation between immobility time and serum BDNF levels. Conclusion: In summary, this study provides confirmation that the fibromyalgia-like model induced by reserpine effectively replicates the symptoms of fibromyalgia. Additionally, it provides evidence supporting the involvement of brain-derived neurotrophic factor (BDNF) in the development of this pain model.

Downloads

Download data is not yet available.

Author Biography

Iraci Lucena da Silva Torres, Post-Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil. Laboratory of Pain Pharmacology and Neuromodulation: Pre-Clinical Research – Center of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil.

DEPARTAMENTO DE FARMACOLOGIA

Published

2024-07-18

How to Cite

1.
Silva de Souza V, Fernandes Medeiros L, Stein DJ, Lino de Oliveira C, Richardt Medeiros H, Dussan-Sarria J, et al. BDNF as a potential biomarker for the fibromyalgia-like model in male wistar rats. Clin Biomed Res [Internet]. 2024 Jul. 18 [cited 2025 Aug. 28];43(4). Available from: https://seer.ufrgs.br/index.php/hcpa/article/view/127156

Most read articles by the same author(s)

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.